Beckloff Associates, Inc. Report issue

For profit Phase 1 Phase 2
Founded: Overland Park KS United States (1976)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2008
NCT00666991
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

melphalan (alkeran) (1 trial)

Drugs in Phase 1 Trials (2)

beinaglutide (1 trial)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 1)

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Peritoneal Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3